Welcome to chemicalbook!
400-158-6606
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook >> Zanamivir-13C,15N2

Zanamivir-13C,15N2

Zanamivir-13C,15N2 price.
  • $426 - $3330
  • Product name: Zanamivir-13C,15N2
  • CAS: 1276528-62-1
  • MF: C12H20N4O7
  • MW: 332.3098
  • EINECS:
  • MDL Number:MFCD28899480
  • Synonyms:Zanamivir-13C,15N2;[13C,15N2]-Zanamivir;Amitriptyline Impurity 2( Amitriptyline EP Impurity B)
3 prices
Selected condition:
Brand
  • Cayman Chemical
  • TRC
  • Usbiological
Package
  • 250μg
  • 1mg
  • 5mg
  • ManufacturerCayman Chemical
  • Product number30733
  • Product descriptionZanamivir-13C,15N2
  • Packaging250μg
  • Price$426
  • Updated2024-03-01
  • Buy
  • ManufacturerTRC
  • Product numberZ148002
  • Product descriptionZanamivir-13C,15N2
  • Packaging5mg
  • Price$3330
  • Updated2021-12-16
  • Buy
  • ManufacturerUsbiological
  • Product number022940
  • Product descriptionZanamivir-13C,15N2
  • Packaging1mg
  • Price$1097
  • Updated2021-12-16
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
Cayman Chemical 30733 Zanamivir-13C,15N2 250μg $426 2024-03-01 Buy
TRC Z148002 Zanamivir-13C,15N2 5mg $3330 2021-12-16 Buy
Usbiological 022940 Zanamivir-13C,15N2 1mg $1097 2021-12-16 Buy

Properties

Melting point :>2400C (dec.)
storage temp. :-20°C Freezer
solubility :Methanol (Slightly), Water (Slightly)
form :Solid
color :White
Water Solubility :Water: slightly soluble
Stability :Hygroscopic

Safety Information

Symbol(GHS):
Signal word:
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
Precautionary statements:

Description

Zanamivir-13C,15N2 is intended for use as an internal standard for the quantification of zanamivir by GC- or LC-MS. Zanamivir is a sialic acid analog that inhibits neuraminidase release of newly replicated influenza virus particles. It has been shown to selectively inhibit the growth of influenza A and B viruses in plaque reduction assays with IC50 values ranging from 5 to 14 nM and to directly inhibit influenza A and B virus neuraminidases with IC50 values ranging from 0.6 to 7.9 nM in vitro. Intranasal zanamivir administration at 0.4 mg/kg twice daily reduces mortality and viral titers in lung homogenates of mice infected with influenza.